This table presents recent patent oppositions filed by Bioverativ Therapeutics, Inc./swedish Orphan Biovitrum Ab (publ) against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP2256135Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation FactorCSL BEHRING GMBHDec 13, 2019